This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: University of California, University of Florida Research Foundation Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 16,008 
1 out of 3,050 
Years Active: 2025
Title: Omar Akil: Innovator in Otoferlin Expression
Introduction
Omar Akil is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of genetic research, particularly in the expression of otoferlin. His work has implications for treating genetic conditions such as Deafness, Autosomal Recessive 9 (DFNB9).
Latest Patents
Omar Akil holds 1 patent for his invention titled "Compositions and methods for expressing otoferlin." This patent outlines methods and compositions for expressing otoferlin, utilizing adeno-associated viral (AAV) particles. The potential applications of this invention are crucial for developing treatments for specific types of hearing loss.
Career Highlights
Throughout his career, Omar has worked with prestigious institutions, including the University of California and the University of Florida Research Foundation, Incorporated. His experience in these organizations has allowed him to collaborate with leading experts in the field.
Collaborations
Omar has collaborated with notable colleagues such as Sanford L Boye and Frank Dyka. Their combined expertise has contributed to advancements in genetic research and therapeutic methods.
Conclusion
Omar Akil's innovative work in otoferlin expression showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of genetic hearing disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile